Intellia Therapeutics Inc (NTLA)
Capital Expenditure
-$2.04M
TTM · Period ending: · USD
NTLA Capital Expenditure
Latest reported-$2.04Mperiod ending
Latest reported-$2.04Mperiod ending
NTLA TTM CapEx (-$2.55M → -$2.04M)
TTM CapEx
High-resolution chart · PNG
NTLA capital expenditure history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -2,043,000 | |
| -473,000 | |
| -1,129,000 | |
| -1,984,000 | |
| -3,234,000 | |
| -4,007,000 | |
| -5,778,000 | |
| -6,317,000 | |
| -9,370,000 | |
| -12,659,000 | |
| -13,985,000 | |
| -16,377,000 | |
| -16,282,000 | |
| -15,961,000 | |
| -58,390,000 | |
| -57,346,000 | |
| -57,647,000 | |
| -56,605,000 | |
| -12,756,000 | |
| -10,894,000 | |
| -7,054,000 | |
| -5,152,000 | |
| -3,585,000 | |
| -5,151,000 | |
| -6,201,000 | |
| -6,106,000 | |
| -6,794,000 | |
| -5,814,000 | |
| -6,082,000 | |
| -6,041,000 | |
| -6,358,000 | |
| -7,163,000 | |
| -7,407,000 | |
| -7,779,000 | |
| -10,091,000 | |
| -11,099,000 | |
| -9,444,000 | |
| -9,319,000 | |
| -6,165,000 | |
| -3,609,000 | |
| -3,606,000 | |
| -3,046,000 | |
| -2,554,000 | |
| -2,117,500 | |
| -1,515,500 |